Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nobuhisa Ueda

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|February 20, 2009
A case of late-onset Tourette's disorder successfully treated with aripiprazole: view from blood levels of catecholamine metabolites and brain-derived neurotrophic factor (BDNF)Atsuko Ikenouchi-Sugita, Reiji Yoshimura, Kenji Hayashi, et al.
Journal of Clinical Pharmacology|November 23, 2011
Comparison of N-acetyltransferase-2 enzyme genotype-phenotype and xanthine oxidase enzyme activity between Swedes and KoreansNatasa Djordjevic, Juan Antonio Carrillo, Hyung-Keun Roh, et al.
Journal of Clinical Pharmacology|August 31, 2010
N-Acetyltransferase-2 (NAT2) gene polymorphisms and enzyme activity in Serbs: unprecedented high prevalence of rapid acetylators in a White populationNatasa Djordjevic, Juan Antonio Carrillo, Nobuhisa Ueda, et al.
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|December 25, 2010
[Blood levels of brain-derived neurotrophic factor (BDNF) in major depressive disorder]Reiji Yoshimura, Atsuko Ikenouchi-Sugita, Hikaru Hori, et al.
Journal of Psychopharmacology (Oxford, England)|October 15, 2009
Predictive factors for responding to sertraline treatment: views from plasma catecholamine metabolites and serotonin transporter polymorphismWakako Umene-Nakano, Reiji Yoshimura, Nobuhisa Ueda, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|August 27, 2009
Olanzapine orally disintegrating tablets (Zyprexa Zydis) rapidly improve excitement components in the acute phase of first-episode schizophrenic patients: an open-label prospective studyHikaru Hori, Nobuhisa Ueda, Reiji Yoshimura, et al.
Experimental Animals|April 19, 2008
Diabetes-associated complications in Spontaneously Diabetic Torii fatty ratsKenichi Matsui, Takeshi Ohta, Tomohiro Oda, et al.
Glycobiology|July 15, 2005
KEGG as a glycome informatics resourceKosuke Hashimoto, Susumu Goto, Shin Kawano, et al.
Human Psychopharmacology|March 3, 2010
Association between plasma nitric oxide metabolites levels and negative symptoms of schizophrenia: a pilot studyYuichiro Nakano, Reiji Yoshimura, Hideki Nakano, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 17, 2009
Adding a low dose atypical antipsychotic drug to an antidepressant induced a rapid increase of plasma brain-derived neurotrophic factor levels in patients with treatment-resistant depressionReiji Yoshimura, Atsuko Ikenouchi-Sugita, Hikaru Hori, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|February 20, 2009
A case of late-onset Tourette's disorder successfully treated with aripiprazole: view from blood levels of catecholamine metabolites and brain-derived neurotrophic factor (BDNF)Atsuko Ikenouchi-Sugita, Reiji Yoshimura, Kenji Hayashi, et al.
Journal of Clinical Pharmacology|November 23, 2011
Comparison of N-acetyltransferase-2 enzyme genotype-phenotype and xanthine oxidase enzyme activity between Swedes and KoreansNatasa Djordjevic, Juan Antonio Carrillo, Hyung-Keun Roh, et al.
Journal of Clinical Pharmacology|August 31, 2010
N-Acetyltransferase-2 (NAT2) gene polymorphisms and enzyme activity in Serbs: unprecedented high prevalence of rapid acetylators in a White populationNatasa Djordjevic, Juan Antonio Carrillo, Nobuhisa Ueda, et al.
Seishin Shinkeigaku Zasshi = Psychiatria Et Neurologia Japonica|December 25, 2010
[Blood levels of brain-derived neurotrophic factor (BDNF) in major depressive disorder]Reiji Yoshimura, Atsuko Ikenouchi-Sugita, Hikaru Hori, et al.
Journal of Psychopharmacology (Oxford, England)|October 15, 2009
Predictive factors for responding to sertraline treatment: views from plasma catecholamine metabolites and serotonin transporter polymorphismWakako Umene-Nakano, Reiji Yoshimura, Nobuhisa Ueda, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|August 27, 2009
Olanzapine orally disintegrating tablets (Zyprexa Zydis) rapidly improve excitement components in the acute phase of first-episode schizophrenic patients: an open-label prospective studyHikaru Hori, Nobuhisa Ueda, Reiji Yoshimura, et al.
Experimental Animals|April 19, 2008
Diabetes-associated complications in Spontaneously Diabetic Torii fatty ratsKenichi Matsui, Takeshi Ohta, Tomohiro Oda, et al.
Glycobiology|July 15, 2005
KEGG as a glycome informatics resourceKosuke Hashimoto, Susumu Goto, Shin Kawano, et al.
Human Psychopharmacology|March 3, 2010
Association between plasma nitric oxide metabolites levels and negative symptoms of schizophrenia: a pilot studyYuichiro Nakano, Reiji Yoshimura, Hideki Nakano, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 17, 2009
Adding a low dose atypical antipsychotic drug to an antidepressant induced a rapid increase of plasma brain-derived neurotrophic factor levels in patients with treatment-resistant depressionReiji Yoshimura, Atsuko Ikenouchi-Sugita, Hikaru Hori, et al.
Pageof 8